Method for distinguishing hereditary material and cell species source of heterogeneity hybridization sample in chimera animal model based on single cell sequencing

By analyzing the transcriptome alignment characteristics and multiple alignment algorithms after single-cell sequencing, single-cell sequencing is directly performed from unlabeled chimeric animal samples, the problem of inability to distinguish between host and chimeric cells in the prior art is solved, and the problem of achieving the goal of distinguishing between host and chimeric cells is achieved. The differentiation of cell sources without the need for sequencing is reduced, reducing cell damage and cost, and improving the accuracy and scope of application of sequencing data.

CN119049567AActive Publication Date: 2024-11-29SHENGYUAN LIFE TECHNOLOGY (ZHEJIANG ANJI) CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411081163.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-29
Estimated Expiration
2044-08-08

AI Technical Summary

Technical Problem

The prior art cannot effectively distinguish between host and chimeric cells in chimeric animal models, and the cell isolation process before single-cell sequencing is prone to change cell biological characteristics or lead to cell damage, resulting in misjudgment of sequencing data and loss of information.

Method used

By analyzing transcriptome alignment characteristics after single-cell sequencing, using multiple alignment algorithms and statistical distribution tests, separation thresholds were calculated to distinguish host and chimeric cells, and tissue samples were directly obtained from unlabeled chimeric animal samples for single-line single-line samples using multiple alignment algorithms and statistical distribution tests. Cell sequencing, avoid cell isolation steps before sequencing.

Benefits of technology

It realizes the distinction between cell sources without the need for sequencing, reduces cell activity damage and cost, expands the scope of application, can better reduce the native state of chimeric model cells, reduce interference, and improves the accuracy of single-cell sequencing data.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119049567A_ABST
    Figure CN119049567A_ABST
Patent Text Reader

Abstract

The invention discloses a method for distinguishing hereditary materials and cell species sources of a heterogeneity hybridization sample in a chimera animal model based on single cell sequencing, which is based on a single cell sequencing technology, does not depend on cell separation before sequencing, and separates a multi-species mixed sample by utilizing multiple genome comparison. The calculation method for separating the multi-species mixture based on the multi-genome ratio comprises the following steps: carrying out statistical distribution modeling according to a genetic material ratio in a result from multiple unsupervised comparison of a sample to a reference genome of a target species; and performing sample source probability prediction according to statistical distribution modeling of the genetic material proportion. The multi-species sample separation method based on the multiple genome ratio established by the invention can be used for accurately judging sources of genetic materials of different species in a heterogeneity hybrid biological sample.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedicine, and specifically, is a method for distinguishing the genetic material and cell species origin of heterogeneous hybrid samples in chimera animal models based on single-cell sequencing. Background Art

[0002] Chimeric animal models are a type of biotechnology widely used in biomedical research. Generally speaking, chimeric animal models are constructed by transplanting chimeric species cells into model organisms, such as transplanting human stem cells into mice. This technology is crucial to biomedical research. Due to scientific research ethics, cost control and other reasons, it is difficult to directly obtain data on the effects of drugs or interventional treatments on humans, and in vitro cell experiments are prone to lack of other biological elements in the human body and lead to deviations. Therefore, by constructing chimeric animal models of human cells and model organisms, it can provide a better platform to explore the effects of drugs or interventional treatments on human cells and living organisms.

[0003] Single-cell sequencing technology can obtain high-throughput sequencing data with cellular resolution and can map transcriptome features to individual cells. Traditionally, if you want to study a chimeric animal model and perform single-cell sequencing on it, the single-cell sequencing data obtained cannot distinguish between chimeric cells and host cells. A common feasible method is to separate cells based on their biological characteristics, such as surface markers, cytological characteristics, and cell density before sending them for single-cell sequencing, and then perform single-cell sequencing on the purified and separated cells. However, on the one hand, this method cannot completely and cleanly separate the host and chimeric cells; on the other hand, the separation process is prone to change the original biological characteristics of the cell biology, or cause cell death and fragmentation, which in turn leads to misjudgment of cell transcription information in the subsequent sequencing process, or even direct loss of a large amount of transcriptome information.

[0004] Therefore, it is of great significance to develop a transcriptome separation method that can separate host and chimeric cell sources by analyzing single-cell-level transcriptome characteristics after sequencing without relying on pre-sequencing cell separation. This method can effectively promote the biological research of existing single-cell sequencing data of chimeric animal models and the understanding of clinical intervention experiments. Summary of the invention

[0005] The present invention is aimed at the defects of the prior art and provides a single-cell transcriptome analysis method that does not rely on cell separation before sequencing, but only analyzes the single-cell transcriptome comparison characteristics in the single-cell sequencing results to distinguish genetic material and cell species origin. At the same time, the program implementation details based on the multiple comparison algorithm and the reasonable changes in the key data processing due to migration to different species but still in accordance with the logic of this algorithm are all within the scope of protection of the technical solution of the present invention.

[0006] The present invention is achieved through the following technical solutions:

[0007] The present invention discloses a method for distinguishing the genetic material and cell species origin of heterogeneous hybrid samples in a chimera animal model based on single-cell sequencing, which specifically comprises the following steps:

[0008] 1) Obtain tissue samples from unlabeled chimeric animals;

[0009] 2) Obtain a mixed cell suspension of tissue samples and directly perform single-cell sequencing without additional labeling, separation, or precipitation;

[0010] 3) Obtaining single-cell transcriptomes of chimeric tissues;

[0011] 4) Multiple alignment of single-cell transcriptomes of chimeric tissues;

[0012] 5) Calculate the multiple alignment separation threshold;

[0013] 6) Separation of host and chimeric cells based on threshold markers.

[0014] As a further improvement, the method of the present invention for distinguishing the origin of genetic material and cell species does not rely on cell separation of chimera biological model samples before sending them for sequencing.

[0015] As a further improvement, the multiple alignment algorithm of the sequence reads of the present invention does not rely on the specific sequence in a particular object, but is based on the statistical distribution test of the cell origin in the comparison results of the host and the chimeric species reference genome.

[0016] Compared with the prior art, the present invention has the following beneficial effects:

[0017] The present invention distinguishes genetic material and cell origin based on the analysis of cell-level transcriptome control features of single-cell sequencing data after sequencing. The advantages of the present invention in distinguishing genetic material and cell origin are mainly manifested in the following conveniences:

[0018] 1) It is not limited to a specific host or chimeric species and has a wide range of applications, and can be applied to chimeric model samples of various species.

[0019] 2) It does not rely on the separation of foster cells before single-cell sequencing, thus minimizing damage to important cell biological and physical and chemical characteristics such as cell activity and cell surface markers.

[0020] 3) It does not rely on the prior labeling of chimera sample cells, such as biomarkers (introducing specific marker gene mutations, etc.) / chemical markers (introducing surface fluorescent groups, etc.) / isotope labeling (using specific isotope labels for specific species during modeling, etc.), thus reducing the cost of chimera model construction, sampling, and sample delivery as much as possible. In addition, it can restore the original state of chimera model cells as much as possible and reduce various interferences. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 Schematic diagram of the analysis steps of the multiple alignment and separation method of the chimeric animal model single cell sequencing results of the present invention. Figure 1 a) Schematic diagram of multi-species chimeric samples collected for the experiment; Figure 1 b) Schematic diagram of single cell dissociation of multi-species chimeric samples; Figure 1 c) Obtain mixed transcriptome data of multiple species for library construction; Figure 1 d) Schematic diagram of the analysis of multiple alignments of the hybrid transcriptome to the host species and the chimeric species to the corresponding reference genome; Figure 1 e) Schematic diagram of the analysis of mapping multiple alignment results to single-cell sequencing reads and storing data in .BAM format; Figure 1 f) is a schematic diagram of the analysis of mapping the single-cell sequencing read alignment results in the .BAM file to each cell; Figure 1 g) Schematic diagram for calculating the ratio of sequencing reads in each cell mapped to different reference genomes; Figure 1 h) is a schematic diagram for calculating the statistical distribution of the mapping ratio of read segments after multiple alignment in all cells and determining the separation threshold ratio; Figure 1 i) is a schematic diagram of separating host species and chimeric species cells in a mixed transcriptome based on a separation threshold ratio.

[0022] Figure 2 This is a schematic diagram of separating human and mouse cells using human bone mesenchymal stem cells (hBMSCs) chimeric mice as an example in Example 1 of the present invention. Figure 2 a) shows a chimeric liver tissue sample of dual-species cells extracted from a chimeric mouse transplanted with hBMSCs; Figure 2 b) indicates that a mixed transcriptome of species was obtained by single-cell sequencing of a bi-species cell chimeric liver sample; Figure 2 c) represents multiple alignments of mixed transcriptomes and mapping of the alignments to individual cells; Figure 2 d) Determine the threshold for species division for statistical distribution of multiple alignment results of single cells; Figure 2 e, f, g) represent the gradient of the cell threshold for dividing species, Figure 2h) is the proportion of human reads in chimeric mouse tissue samples with a screening threshold of greater than 90%.

[0023] Figure 3 The data of the human and mouse cell separation results in Example 1 of the present invention. Figure 3 a) Dimensionality reduction cluster analysis diagram of human-mouse mixed cells in the separation results; Figure 3 b) is the flow cytometry identification result of human-mouse mixed cells in the separation results.

[0024] Figure 4 It is a schematic diagram comparing the separation and sequencing method based on flow cytometry separation technology of the present invention and that of the present invention.

[0025] in Figure 4 a) Sampling after hBMSC cell transplantation in mice; Figure 4 b) for identifying human cells based on human-specific markers; Figure 4 c) for separating human cells using flow cytometry; Figure 4 d) Indicates sequencing of isolated human cells.

[0026] Figure 5 Schematic diagram of the comparison between the present invention and the separation and sequencing method based on gene editing and magnetic bead elution technology not using the present invention. Figure 5 a) indicates genetic modification of human cells; Figure 5 b) The modified hBMSC cells were transplanted into mice to establish the model and samples were taken; Figure 5 c) indicates the elution of human cells using modified target binding magnetic beads; Figure 5 d) Indicates sequencing of isolated human cells. DETAILED DESCRIPTION

[0027] The technical solution of the present invention is further described below by means of specific embodiments, which do not limit the protection scope of the present invention. Some non-essential modifications and adjustments made by others based on the concept of the present invention still fall within the protection scope of the present invention.

[0028] refer to Figure 1 The present invention provides a multiple alignment and separation method for single-cell sequencing results of a chimeric animal model, which specifically comprises the following steps:

[0029] 1. As attached Figure 1 a) Obtaining chimeric tissue cell samples as shown: It should be noted that the tissue samples are obtained from chimeric animal samples that have not been additionally labeled, and a mixed species cell suspension of the tissue sample is prepared without additional labeling, separation, and precipitation treatment.

[0030] 2. As attached Figure 1b) As shown, the mixed species cell suspension of the tissue sample processed in step 1 is loaded onto the chimeric tissue single-cell sequencer.

[0031] 3. As attached Figure 1 c) The library was constructed and sequencing was performed to obtain single-cell transcriptome data of chimeric tissues.

[0032] 4. As attached Figure 1 d) shows the alignment of multiple species reference genomes:

[0033] 1) Compare the obtained single-cell transcriptome data of chimeric tissues with the standard sequence library of the host species;

[0034] 2) Compare the obtained single-cell transcriptome data of chimeric tissues with the standard sequence library of chimeric species;

[0035] It should be noted that the host species standard sequence library and the chimeric species standard sequence library used in the present invention refer to the internationally recognized and widely used reference genome sequence library of the species; and the genome sequence library should contain all nucleotide sequence contents, including the sequences of genes corresponding to protein-coding proteins and all other non-coding sequences; if the species is not a model species, it should be compared with the "de novo alignment and assembly reference genome" that is as comprehensive as possible.

[0036] 5. As attached Figure 1 e) shows mapping the comparison results to the sequencing reads:

[0037] 1) Extracting the alignment information of each cell from the host species standard sequence alignment results;

[0038] 2) extracting the alignment information of each cell from the chimeric species standard sequence alignment results;

[0039] It should be noted that the alignment information of each cell extracted from the above standard sequence alignment results comes from the SAM format in the alignment algorithm results or other files that record the alignment results of each sequencing sequence read. The extracted fields should fully describe whether the alignment is successful, the alignment position, the alignment quality and whether there are multiple alignments.

[0040] 6. As attached Figure 1 f) shows mapping the contrast results to individual cells.

[0041] 7. As attached Figure 1 g) Calculate the ratio of reads mapping between species in each cell:

[0042] 1) Calculate the number of sequence reads that are successfully mapped to the host species standard sequence library for each cell;

[0043] 2) Calculate the number of sequence reads successfully mapped to the chimeric species standard sequence library for each cell;

[0044] 3) Calculate the proportion of sequence reads that are successfully aligned to the two standard sequence libraries for each cell.

[0045] 8. As attached Figure 1 h) Statistics of the mapping distribution of reads between species in all cells are shown to determine the separation threshold:

[0046] 1) The ratio of successful multiple alignments for each cell is used as a candidate for the threshold;

[0047] 2) Determine the multiple alignment success ratio separation threshold to be more than 90%, which can also be adjusted based on the estimated chimerism rate of the sample.

[0048] 9. As attached Figure 1 i) The indicated threshold markers separate host and chimeric cells:

[0049] 1) According to the set host species threshold, cells with a multiple alignment success ratio greater than the threshold are marked as host cells;

[0050] 2) Separate the single-cell transcriptome sequencing data based on the labeled cell barcode.

[0051] Example 1: Isolation of human and mouse cells using human bone marrow mesenchymal stem cell (hBMSC) chimeric mice as an example

[0052] refer to Figure 2-5 The multi-species sample separation method based on multiple genome comparisons of the present invention was applied to the liver single-cell sequencing results of mice transplanted with hBMSC cells, and the results were compared with the traditional chimera sample separation method. The specific results are as follows:

[0053] Samples were collected from the liver of a mouse model that received hBMSC transplantation and contained both human and mouse cells and were prepared according to the 10xGenome single-cell sequencing platform workflow standard ( Figure 2 a); Single-cell loading of human-mouse dual-species chimeric liver samples was performed, library construction and sequencing were performed to obtain dual-species mixed single-cell transcriptomes, and transcriptome data were stored in .BAM file format ( Figure 2 b); then the single-cell transcriptome data stored in .BAM format were aligned to the two-species reference genome to obtain the inter-species ratio of human and mouse single-cell sequencing reads in each cell transcriptome ( Figure 2 c);

[0054] Draw a distribution map of multi-species read ratios based on the proportion of all cells aligned to the dual-species reference genome sequencing reads ( Figure 2d). In this figure, the horizontal axis indicates the proportion of transcriptome sequencing reads in each cell that are mapped to the human reference genome; the dark line indicates the number of cells with reads successfully mapped to the human reference genome greater than the threshold when the human read proportion indicated by the current horizontal axis is the threshold; the light line indicates the overall proportion of reads successfully mapped to the human reference genome when the human read proportion indicated by the current horizontal axis is the threshold.

[0055] Furthermore, based on the estimated proportion of chimeric human cells in mouse liver, combined with the proportion of successful read alignment and the proportion of successful cell alignment, three observed proportions were set as threshold candidates according to the equal rate interval, median decline interval, and terminal stable value convergence interval between the two proportion curves (indicated by light-colored dotted lines): (i) 50% human read proportion ( Figure 2 e), (ii) 70% human reads ( Figure 2 f), (iii) 90% human reads ratio ( Figure 2 g).

[0056] Furthermore, based on observations of chimeric mouse tissue samples, the screening threshold was set to a human read ratio greater than 90% ( Figure 2 h); cells with a value greater than the threshold (in the lower right solid line box) are marked as human cells, the cell barcode is obtained, and the transcriptome single-cell data that matches the barcode of this group of human cells in the transcriptome are extracted to complete the separation of human cells and mouse cells.

[0057] Finally, the results of human and mouse cell separation in Example 1 of the present invention are as follows Figure 3 shown.

[0058] Figure 3 a shows the dimensionality reduction cluster analysis data of human-mouse mixed cells in the separation results. Specifically, a total of 10310 cells were detected after 10x single-cell sequencing; after dimensionality reduction cluster analysis, two main cell groups i) and ii) that were clearly separated can be seen. After implementing this method, the cells are marked as human cells and mouse cells according to the comparison ratio of the genetic material in each detected cell. As can be seen in the figure, the gray dots are marked as mouse cells after separation, and the black triangle scattered points are human cells.

[0059] Furthermore, it can be clearly seen that i) all cells in the group are mouse cells, indicating that the mouse genetic characteristics of the cells in this group are relatively obvious, and generally speaking, the mouse cells in this group can be separated relatively smoothly using traditional methods; and ii) there are both human cells and mouse cells in the group of cells, and it is determined that this group is a mixed group of human and mouse cells. This result shows that there is a lack of significant separable human and mouse genetic characteristics within the group of cells, and it is difficult to further extract human cells from this group of cells using traditional methods. However, after multiple comparison and labeling of human and mouse cells using the patented method, they were successfully identified, and targeted downstream separation and analysis of human cells can be performed in subsequent analysis.

[0060] In this example, the result is that after separation, a total of 901 cells were labeled as human cells, and the current chimerism rate was inferred to be 8.74%, which is consistent with the estimated chimerism rate of human cells of 5%-10% for human-mouse chimerism.

[0061] Subsequently, the human-mouse mixed cells in the separation results were analyzed by cell flow cytometry, and the results were as follows: Figure 3 As shown in Figure b, the horizontal axis is the expression intensity of human-specific surface markers, and the vertical axis is the expression intensity of standard cell activity by flow cytometry. The black frame is a group of cell subpopulations that are more clearly separated from the main cell population. This group of cells has a high level of human cell-specific surface markers and can be considered to be human cells. The proportion of cells with high expression of human-specific markers is 7.95%, which is consistent with the expected proportion of human cell chimerism in the mouse model.

[0062] Furthermore, by comparing the results with those of a multi-species sample separation method based on multiple genome alignments, the proportion of human cells identified by flow cytometry was close, successfully verifying that this method can successfully separate human cells.

[0063] Furthermore, some human cells do not have specific surface markers and therefore cannot be separated in the cell flow cytometer, so the human cell ratio is slightly lower than the separation result of this method. This also shows that the human cell types included in the separation results of this method are more comprehensive and closer to the actual distribution of human cells in the sample.

[0064] The present invention is compared with the existing traditional mixed species cell separation technology as follows:

[0065] Comparative Example 1: Pre-sequencing separation method based on human cell surface specific expression markers

[0066] Please refer to Figure 4 Procedure, sampling from the liver of a mouse model containing human and mouse dual-species cells that received hBMSC transplantation ( Figure 4 a); Identify human cells based on human cell-specific markers such as hCD45 ( Figure 4b); Use flow cytometry to separate and capture human cells that highly express the marker ( Figure 4 c); The captured human cells are sent for single-cell sequencing ( Figure 4 d).

[0067] The advantages of the method of the present invention are embodied in the following aspects:

[0068] Advantage 1: The method of the present invention does not require the separation of human cells before sequencing, the process steps are simpler and the initial cost is lower;

[0069] Advantage 2: The method of the present invention includes all types of human cells, and does not miss human cells that lack specific surface markers;

[0070] Advantage 3: The method of the present invention directly sequences the cell suspension, avoiding damage to the cells during the separation step.

[0071] Comparative Example 2: Sequencing separation method based on the construction of artificial markers for gene modification

[0072] Please refer to Figure 5 process, genetically modifying human cells prior to transplantation to express specific surface markers ( Figure 5 a); liver samples were taken from a mouse model containing both human and mouse cells that received hBMSC transplantation ( Figure 5 b); Use probe protein to bind to genetically modified human cells and capture them using magnetic beads ( Figure 5 c); The captured human cells are sent for single-cell sequencing ( Figure 5 d).

[0073] The advantages of the method of the present invention are embodied in the following aspects:

[0074] Advantage 1: The method of the present invention does not require genetic modification of human cells before transplantation, and retains the native biological characteristics of the cells to the greatest extent.

[0075] Advantage 2: The method of the present invention has simpler steps and saves the cost of genetically modifying specific human cells.

[0076] Advantage 3: The method of the present invention directly sequences the cell suspension, avoiding damage to cells caused by probe protein binding to magnetic beads and magnetic capture, as well as artificial changes in cell biological characteristics.

Claims

1. A multi-species sample separation method based on multiple genome comparisons, characterized in that: A method for distinguishing the biological origin of heterogeneous hybrid biological samples is established, and the steps of the method are as follows: 1) Obtain tissue samples from chimeric animals without additional labeling; 2) Obtain a mixed cell suspension of tissue samples and directly perform single-cell sequencing without additional labeling, separation, or precipitation; 3) Obtain single-cell transcriptomes of chimeric tissues; 4) Multiple alignments were performed independently for each cell in the single-cell transcriptome of the chimeric tissue; 5) Compare each cell sequencing read to the host and chimeric species standard reference genomes respectively; 6) Incorporating the host and chimeric species alignment records of each cell into the statistical distribution analysis to obtain the statistical distribution pattern of the multiple alignment results of all cells; 7) Calculate the multiple alignment separation threshold; 8) Separation of host and chimeric cells based on threshold markers.

2. The multi-species sample separation method based on multiple genome comparisons according to claim 1, characterized in that: The alignment information of each cell extracted from the standard sequence alignment results in step 4-5) comes from the file of the alignment results of the sequencing sequence reads in the alignment algorithm results, and the extracted fields include the results of successful alignment, alignment position, alignment quality and multiple alignment results.

3. The multi-species sample separation method based on multiple genome comparison according to claim 1, characterized in that: The specific steps of the steps 6-7) are as follows: a. Statistical analysis of the multiple alignment results of single-cell transcriptomes of chimeric tissues, and the distribution of the successful alignment ratios of host and chimeric cells in all cells; b. Draw a distribution curve of the successful comparison ratio according to the probability of multiple comparison results; c. Calculate the rate of change of the successful comparison ratio in each distribution interval according to the successful comparison ratio distribution curve; d. Calculate the separation threshold based on the rate of change and with reference to the specific experimental observations of the chimeric sample.

4. The multi-species sample separation method based on multiple genome comparisons according to claim 3, characterized in that: The specific steps of step a are as follows: 1) Calculate the number of sequence reads that are successfully mapped to the host species standard sequence library for each cell; 2) Calculate the number of sequence reads successfully mapped to the chimeric species standard sequence library for each cell; 3) Calculate the proportion of sequence reads that are successfully aligned to the two standard sequence libraries for each cell; 4) Map the number of cells to each sequence read ratio interval to calculate the cell ratio; 5) Count the cell distribution of each sequence read ratio interval.

5. The multi-species sample separation method based on multiple genome comparison according to claim 3, characterized in that: The specific steps of step d are as follows: taking the multiple alignment success ratio of each cell as a candidate for the threshold, and determining the multiple alignment success ratio separation threshold according to the estimated mosaic rate of the sample and the statistical distribution pattern of the multi-species alignment results of all cell sequencing reads in the single-cell sequencing results.

6. The multi-species sample separation method based on multiple genome comparisons according to claim 5, characterized in that: The threshold is selected to be more than 90% of the target species' successful alignment rate as the threshold for identifying the species' cells, and the threshold is also adjusted according to the actual cell chimera ratio. The statistical distribution pattern of the multi-species alignment results of all cell sequencing reads in the single-cell sequencing results is also referred to, and the final selected threshold for the species' cells should be within the range where the alignment success ratio has tended to be stable.

7. The multi-species sample separation method based on multiple genome comparison according to claim 1, characterized in that: The specific steps of step 8) are as follows: a. According to the set host species threshold, cells with a multiple alignment success ratio greater than the threshold are marked as host cells; b. Separate single-cell transcriptome sequencing data based on markers.

Citation Information

Patent Citations

  • Method and system for determining mitochondria genome sequence information of various samples at the same time

    CN105653899A

  • Single cell transcriptome calculation and analysis method and system fused with deep learning model

    CN115050416A

  • PDX model single cell transcriptome data analysis method, device and medium

    CN117912552A

  • Single cell classification method, gene screening method and device thereof

    US20140206006A1

  • Rapid single-cell multiomics processing using an executable file

    US20240038327A1